TY - JOUR
T1 - Clinical outcomes of patients referred for asymptomatic neutropenia
T2 - A focus on racial disparities in hematology
AU - Oyogoa, Emmanuella
AU - Mathews, Rick
AU - Olson, Sven
AU - DeLoughery, Thomas
AU - Shatzel, Joseph J.
AU - Martens, Kylee L.
N1 - Publisher Copyright:
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2023/7
Y1 - 2023/7
N2 - Background: Asymptomatic neutropenia is a common hematology referral, though standardized reference ranges and published clinical outcomes are lacking. Methods: In our retrospective analysis, we evaluated demographics, laboratory, and clinical outcomes of adult patients referred to an academic hematology practice for evaluation of neutropenia from 2010 to 2018. Primary and secondary outcomes included incidence of hematologic disorders and rates of Duffy-null positivity by race, respectively. In a separate analysis, we reviewed absolute neutrophil count (ANC) reference ranges from publicly available Association of American Medical Colleges Medical School Member laboratory directories to assess institutional variations. Results: In total, 163 patients were included, with disproportionate number of Black patients referred compared to local demographics. Twenty-three percent of patients (n = 38) were found to have a clinically relevant hematologic outcome (mean ANC of 0.59 × 109/L), and only six were identified with ANC ≥1.0 × 109/L. Incidence of hematologic outcomes was lowest among Black patients (p =.05), and nearly all Blacks who underwent Duffy-null phenotype testing were positive (93%), compared to 50% of Whites (p =.04). In separate review of laboratory directories, we confirmed wide variation in ANC lower limit of normal (0.91–2.40 × 109/L). Conclusion: Hematologic disorders were rare in patients with mild neutropenia and among Blacks, highlighting the need to standardize hematological ranges representative of non-White communities.
AB - Background: Asymptomatic neutropenia is a common hematology referral, though standardized reference ranges and published clinical outcomes are lacking. Methods: In our retrospective analysis, we evaluated demographics, laboratory, and clinical outcomes of adult patients referred to an academic hematology practice for evaluation of neutropenia from 2010 to 2018. Primary and secondary outcomes included incidence of hematologic disorders and rates of Duffy-null positivity by race, respectively. In a separate analysis, we reviewed absolute neutrophil count (ANC) reference ranges from publicly available Association of American Medical Colleges Medical School Member laboratory directories to assess institutional variations. Results: In total, 163 patients were included, with disproportionate number of Black patients referred compared to local demographics. Twenty-three percent of patients (n = 38) were found to have a clinically relevant hematologic outcome (mean ANC of 0.59 × 109/L), and only six were identified with ANC ≥1.0 × 109/L. Incidence of hematologic outcomes was lowest among Black patients (p =.05), and nearly all Blacks who underwent Duffy-null phenotype testing were positive (93%), compared to 50% of Whites (p =.04). In separate review of laboratory directories, we confirmed wide variation in ANC lower limit of normal (0.91–2.40 × 109/L). Conclusion: Hematologic disorders were rare in patients with mild neutropenia and among Blacks, highlighting the need to standardize hematological ranges representative of non-White communities.
KW - ethnic and racial minorities
KW - health care
KW - healthcare disparities
KW - hematologic diseases
KW - minority health
KW - neutropenia
KW - outcome assessment
UR - http://www.scopus.com/inward/record.url?scp=85151958028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85151958028&partnerID=8YFLogxK
U2 - 10.1111/ejh.13963
DO - 10.1111/ejh.13963
M3 - Article
C2 - 36951011
AN - SCOPUS:85151958028
SN - 0902-4441
VL - 111
SP - 41
EP - 46
JO - European Journal of Haematology
JF - European Journal of Haematology
IS - 1
ER -